Evidence map›Paper›PMID 18073192›Full record

ArticleNucleic acids research2008

Protein evolution by hypermutation and selection in the B cell line DT40.

Hiroshi Arakawa, Hiroaki Kudo, Vera Batrak, Randolph B Caldwell, Michael A Rieger, Joachim W Ellwart, Jean-Marie Buerstedde

Abstract readEvaluation Study
In one paragraph

Article in Nucleic acids research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Rapid directed molecular evolution of fluorescent proteins in mammalian cells.Protein science : a publication of the Protein Society · 2022
    Article
  5. Observing and Quantifying Fluorescent Reporters.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  6. In vitro affinity maturation of broader and more-potent variants of the HIV-1-neutralizing antibody CAP256-VRC26.25.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Directed evolution of human scFvs in DT40 cells.Protein engineering, design & selection : PEDS · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hiroshi ArakawaInstitute for Molecular Radiobiology, Institute of Stem Cell Research, GSF-National Research Center for Environment and Health, Ingolstaedter Landstrasse 1, D-85764 Neuherberg-Munich, Germany.
Hiroaki Kudo
Vera Batrak
Randolph B Caldwell
Michael A Rieger
Joachim W Ellwart
Jean-Marie Buerstedde

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide mutations and selection within a population are the basis of natural evolution. A similar process occurs during antibody affinity maturation when immunoglobulin genes are hypermutated and only those B cells which express antibodies of improved antigen-binding specificity are expanded. Protein evolution might be simulated in cell culture, if transgene-specific hypermutation can be combined with the selection of cells carrying beneficial mutations. Here, we describe the optimization of a GFP transgene in the B cell line DT40 by hypermutation and iterative fluorescence activated cell sorting. Artificial evolution in DT40 offers unique advantages and may be easily adapted to other transgenes, if the selection for desirable mutations is feasible.

Indexed as

Somatic Hypermutation, ImmunoglobulinAmino Acid SequenceAnimalsBase SequenceB-LymphocytesCell LineCell SeparationChickensDirected Molecular EvolutionDNA Mutational AnalysisFlow CytometryFluorescent DyesGene TargetingGenetic VectorsGreen Fluorescent ProteinsImmunoglobulin Light Chainsenhanced green fluorescent proteinFluorescent DyesGreen Fluorescent ProteinsImmunoglobulin Light Chains

Identifiers

PMID18073192
PMCPMC2248763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.